tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks 50 IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

LENZ Stock Latest News

Lenz Therapeutics’ Earnings Call Highlights Strong Outlook
Company AnnouncementsLenz Therapeutics’ Earnings Call Highlights Strong Outlook
19d ago
LENZ
Lenz Therapeutics, Lotus enter license, commercialization agreement for LNZ100
PremiumThe Fly
Lenz Therapeutics, Lotus enter license, commercialization agreement for LNZ100
19d ago
LENZ
LTUS
LENZ Therapeutics Positioned for Success with LNZ100 Ahead of 2025 PDUFA Date
PremiumRatings
LENZ Therapeutics Positioned for Success with LNZ100 Ahead of 2025 PDUFA Date
20d ago
LENZ
Positive Outlook for LENZ Therapeutics: Buy Rating Affirmed Amid Regulatory Progress and Strategic Positioning
PremiumRatings
Positive Outlook for LENZ Therapeutics: Buy Rating Affirmed Amid Regulatory Progress and Strategic Positioning
20d ago
LENZ
Strong Buy Recommendation for LENZ Therapeutics: LNZ100 Poised to Disrupt Presbyopia Market with Best-in-Class Efficacy and Safety
PremiumRatings
Strong Buy Recommendation for LENZ Therapeutics: LNZ100 Poised to Disrupt Presbyopia Market with Best-in-Class Efficacy and Safety
21d ago
LENZ
Promising Potential of LENZ Therapeutics’ LNZ100: A Buy Recommendation by Matthew Caufield
PremiumRatingsPromising Potential of LENZ Therapeutics’ LNZ100: A Buy Recommendation by Matthew Caufield
1M ago
LENZ
LENZ Therapeutics Hosts Commercial Day for LNZ100
Premium
Company Announcements
LENZ Therapeutics Hosts Commercial Day for LNZ100
1M ago
8K
LENZ
Lenz Therapeutics assumed with an Overweight at Piper Sandler
Premium
The Fly
Lenz Therapeutics assumed with an Overweight at Piper Sandler
1M ago
ABBV
LENZ
new option listings on April 9th
PremiumThe Fly
new option listings on April 9th
2M ago
LIF
MBX
Lenz Therapeutics files to sell 13.07M shares of common stock for holders
PremiumThe Fly
Lenz Therapeutics files to sell 13.07M shares of common stock for holders
2M ago
LENZ
Lenz Therapeutics files $500M mixed securities shelf
PremiumThe Fly
Lenz Therapeutics files $500M mixed securities shelf
2M ago
LENZ
Lenz Therapeutics’ Earnings Call Highlights Positive Outlook
PremiumCompany Announcements
Lenz Therapeutics’ Earnings Call Highlights Positive Outlook
2M ago
LENZ
Promising Outlook for LENZ Therapeutics: Buy Rating Affirmed Amid Strong Market Position and Upcoming Product Launch
PremiumRatingsPromising Outlook for LENZ Therapeutics: Buy Rating Affirmed Amid Strong Market Position and Upcoming Product Launch
2M ago
LENZ
Lenz Therapeutics price target raised to $38 from $37 at BofA
Premium
The Fly
Lenz Therapeutics price target raised to $38 from $37 at BofA
2M ago
LENZ
LENZ Therapeutics: Innovative Presbyopia Treatment and Strategic Growth Reinforce Buy Rating
Premium
Ratings
LENZ Therapeutics: Innovative Presbyopia Treatment and Strategic Growth Reinforce Buy Rating
2M ago
LENZ
Promising Outlook for LENZ Therapeutics: Buy Rating Backed by Strategic Marketing and Anticipated FDA Approval
PremiumRatings
Promising Outlook for LENZ Therapeutics: Buy Rating Backed by Strategic Marketing and Anticipated FDA Approval
2M ago
LENZ
Lenz Therapeutics price target raised to $47 from $44 at Citi
PremiumThe Fly
Lenz Therapeutics price target raised to $47 from $44 at Citi
2M ago
LENZ
Promising Outlook for LENZ Therapeutics: Buy Rating Affirmed Amid FDA Progress and Commercial Readiness
PremiumRatings
Promising Outlook for LENZ Therapeutics: Buy Rating Affirmed Amid FDA Progress and Commercial Readiness
2M ago
LENZ
Buy Rating for LENZ Therapeutics Driven by Promising LNZ100 Eye Drop Prospects
PremiumRatings
Buy Rating for LENZ Therapeutics Driven by Promising LNZ100 Eye Drop Prospects
2M ago
LENZ
Lenz Therapeutics reports Q4 EPS (46c), consensus (40c)
PremiumThe FlyLenz Therapeutics reports Q4 EPS (46c), consensus (40c)
2M ago
LENZ
Closing Bell Movers: Harrow spikes 24% on revenue beat, leverage update
Premium
The Fly
Closing Bell Movers: Harrow spikes 24% on revenue beat, leverage update
2M ago
NGS
BKKT
Lenz Therapeutics initiated with a Buy at TD Cowen
Premium
The Fly
Lenz Therapeutics initiated with a Buy at TD Cowen
2M ago
LENZ

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >